Gundersen Kjell Gunnar, Potvin Richard
IFocus Øyeklinikk AS, Haugesund, Norway.
Science in Vision, Bend, OR, USA.
Clin Ophthalmol. 2022 Jun 9;16:1861-1869. doi: 10.2147/OPTH.S366145. eCollection 2022.
To evaluate the range of vision, visual function, and quality of vision after implantation of a secondary extended depth of focus intraocular lens (EDOF IOL) implanted in the sulcus.
One clinical practice in Haugesund, Norway.
Prospective single arm non-interventional study.
Eligible subjects presenting for surgery, or who had previous successful primary cataract or refractive lens exchange surgery in both eyes were subsequently implanted with the AddOn® secondary EDOF IOL in the sulcus. Manifest refraction and visual acuity at distance, intermediate and near were measured 3 months after surgery, along with the monocular defocus curve. Subjects also completed a visual function and a quality of vision questionnaire.
The study included 32 eyes of 16 subjects. At 3 months postoperative, the mean refraction spherical equivalent (MRSE) was -0.16 ± 0.30 D, with a residual cylinder of 0.29 ± 0.27 D. The mean monocular uncorrected VA was 0.1 logMAR (20/25) or better at all test distances. The monocular defocus curves showed a depth of focus of 2.0 D. For every category except reading fine print, all but one subject (94%) had no difficulty or little difficulty with near tasks. Glare and halos were the most common visual disturbances, with no reports of starbursts. There was no evidence of any intralenticular opacification in any of the eyes, and no evidence of iris chafing/depigmentation.
This secondary EDOF IOL provided excellent distance and intermediate vision, and very good near vision to subjects. Subject reported near visual function was also very good and visual disturbances were limited. This lens appears to be a good option for patients who would like to improve their range of vision. Results appear as good or better than those reported for primary EDOF lenses.
评估在睫状沟植入第二代扩展景深人工晶状体(EDOF IOL)后的视力范围、视觉功能和视觉质量。
挪威豪格松的一家临床诊所。
前瞻性单臂非干预性研究。
符合条件的手术患者,或既往双眼白内障手术或屈光性晶状体置换手术成功的患者,随后在睫状沟植入AddOn®第二代EDOF IOL。术后3个月测量远、中、近视力的显验光和视力,以及单眼散焦曲线。受试者还完成了视觉功能和视觉质量问卷。
该研究纳入了16名受试者的32只眼。术后3个月,平均等效球镜度(MRSE)为-0.16±0.30 D,残余散光为0.29±0.27 D。在所有测试距离下,单眼未矫正视力平均为0.1 logMAR(20/25)或更好。单眼散焦曲线显示景深为2.0 D。除阅读小字体外,所有类别中,除一名受试者外(94%),几乎所有人在近视力任务中都没有困难或只有轻微困难。眩光和光晕是最常见的视觉干扰,没有星芒现象的报告。所有眼中均未发现任何晶状体混浊迹象,也没有虹膜摩擦/色素脱失的迹象。
这种第二代EDOF IOL为受试者提供了出色的远、中视力和良好的近视力。受试者报告的近视力功能也非常好,视觉干扰有限。对于希望扩大视力范围的患者来说,这种晶状体似乎是一个不错的选择。结果似乎与第一代EDOF晶状体报告的结果一样好或更好。